Table 2 Distribution of urinary uroporphyrines (μmol/L) and serum concentrations of organochlorinated compounds (ng/mL) (n = 241 subjects)
% detectable | Percentiles among detectables | |||||
|---|---|---|---|---|---|---|
Min | p25 | p50 | p75 | Max | ||
Total porphyrins | 100% | 13.0 | 63.8 | 98.5 | 157 | 497 |
Uro I | 36% | 2.0 | 6.0 | 10.0 | 16.0 | 37.0 |
Uro III | 2% | 1.0 | 1.0 | 1.0 | 8.0 | 8.0 |
Hepta I | 1% | 2.0 | 2.0 | 2.5 | 3.0 | 3.0 |
Hepta III | 6% | 2.0 | 2.8 | 4.0 | 6.8 | 13.0 |
Copro I | 76% | 1.0 | 4.0 | 7.0 | 14.0 | 134 |
Copro III | 86% | 2.0 | 10.0 | 21.5 | 37.0 | 154 |
HCB | 100% | 2.30 | 13.2 | 21.7 | 37.9 | 1616 |
DDE | 97% | 0.1 | 2.59 | 6.15 | 14.4 | 67.4 |
Total PCBs† | 94% | 0.2 | 1.89 | 3.78 | 7.02 | 143 |
CB-138 | 87% | 0.1 | 0.58 | 1.03 | 1.85 | 35.0 |
CB-153 | 85% | 0.1 | 0.67 | 1.18 | 2.32 | 40.9 |
CB-180 | 89% | 0.1 | 0.58 | 1.43 | 2.66 | 63.5 |